United States · FDA National Drug Code directory

Pazopanib

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
0480-4184_048bbf33-5176-40b9-a6ed-ee377d7d078b
Product NDC
0480-4184
Form
TABLET, FILM COATED
Composition / generic term
Pazopanib
Labeler
Teva Pharmaceuticals, Inc.
Marketing category
ANDA
Marketing start / end (source format)
20231020
Source listing expiry
20261231

Source-listed ingredients

  • PAZOPANIB HYDROCHLORIDE — 200 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 120 TABLET, FILM COATED in 1 BOTTLE (0480-4184-89) · 0480-4184-89

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →